معرفی
Wei Qiu serves as Associate Senior Lecturer in the Division for Biomedical Engineering at Lund University's Faculty of Engineering (LTH) and holds Principal Investigator status at NanoLund: Centre for Nanoscience. He actively contributes to Lund's Profile Areas in Engineering Health, Nanoscience and Semiconductor Technology, and Light and Materials, driving interdisciplinary research at the intersection of acoustics and biomedical engineering.
His research program centers on acoustofluidic systems with expertise in ultrasonics, thermoacoustic streaming, and microscale particle manipulation. Key focus areas include blood plasma separation without centrifugation, high-throughput nanoparticle handling, and temperature-gradient-enhanced acoustic streaming. His work bridges fundamental fluid mechanics with clinical applications, particularly in minimally invasive diagnostics and single-cell analysis where conventional methods face limitations.
Analysis of his recent publications reveals a strong trajectory toward optimizing acoustic energy density through novel transducer geometries (double-parabolic, elliptical reflector) and thermal modulation techniques. This enables breakthrough applications in blood sampling with reduced volume requirements, nanoparticle separation in complex fluids, and configurable microfluidic manipulation - addressing critical gaps in point-of-care diagnostics and nanomanufacturing.
No scientific awards are documented in the available information.
Dr. Qiu currently leads four major externally funded projects: acoustic holography for cell stimulation (Crafoord Foundation, 2025-2028), high-throughput nanoparticle manipulation (Carl Tryggers Stiftelse, 2024-2026), single-cell mechanotyping (Swedish Research Council, 2022-2026), and non-Newtonian acoustofluidics (Crafoord Foundation, 2023-2024). His supervisory record includes doctoral research as evidenced by one completed thesis.
Integrated within NanoLund's ecosystem, he collaborates extensively across Lund's engineering and medical faculties, particularly through the Engineering Health profile area. His team develops next-generation acoustofluidic platforms combining ultrasonic transducers with microfluidic channels to create label-free, rapid diagnostic tools for clinical and research applications.
